Search Results 781-790 of 18872 for Insulin

1. Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma - Mayo Clinic

   Note: Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not ...

2. Phase IIB Study Of PHENOGENE-1A (Cromolyn) As An Adjuvant Therapy In Mild To Moderate ALS - Mayo Clinic

   Taking inhaled protein products on a chronic basis (such as insulin, parathyroid hormone, etc). 11. Subjects with a body weight of 32 kg or less, or a body ...

3. A Study to Evaluate the Effect of Olorinab on Gastrointestinal Transit in Patients with Irritable Bowel Syndrome - Mayo Clinic

   History of insulin-dependent diabetes mellitus. Significant history or clinical manifestation of any endocrine, allergic, dermatological, hepatic, renal ...

4. Brain MRI (brain magnetic resonance imaging) - Mayo Clinic

   Devices implanted in the body to deliver medicines, such as insulin. Devices used to expand tissues. Pieces of shrapnel or bullets. Any implant with a ...

5. Progeria - Symptoms and causes - Mayo Clinic

   Insulin resistance, which means the body doesn't respond well to insulin made by an organ called the pancreas. When to see a doctor. Progeria is usually ...

6. Calcium supplements: Do they interfere with blood pressure drugs? - Mayo Clinic

   Will I need a kidney transplant? IgA nephropathy (Berger disease) · Insulin and weight gain: Keep the pounds off · Intracranial hematoma · Isolated systolic ...

7. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

   Stable diabetes mellitus on non-insulin therapy;; Sjogren's syndrome. Current or prior use of immunosuppressive medication < 14 days prior to registration ...

8. Study to Analyze Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy - Mayo Clinic

   Patients are eligible if they have controlled diabetes on diet, oral agents, and/or insulin. Age ≥ 18 years old; ECOG Performance Status 0, 1 or 2. Patients ...

9. 2024 hurricane preparedness: Be ready for storm season - Mayo Clinic News Network

   For example, if you take insulin daily, make sure you have enough available for several days in case pharmacies are closed. Prepare for others: If you have ...

10. Testosterone in Treating Postmenopausal Patients with Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment - Mayo Clinic

    ... insulin, oral or injectable vitamin D doses over 4,000 IU/day or tamoxifen. Participating Mayo Clinic locations. Study statuses change often. Please contact ...